Announce Date | 05/01/2025 |
EPS Normalized Actual | $1.15 (Miss by $-0.26) |
EPS GAAP Actual | $1.15 (Miss by $-0.26) |
Revenue Actual | $2.5258B |
Revenue Surprise | Beat by $2525.8M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 15.91 | 6.68 | 15.04741 | 16.41153 | 1 |
Dec 2028 | 16.35 | 6.5 | 15.68777 | 16.70982 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.16 | 1.16 | 2.5258B | -6.08% | 2525.8M |
FQ4 2024 (Dec 2024) | 1.48 | 1.48 | 2.6372B | 0.94% | 2637.2M |
FQ3 2024 (Sep 2024) | 2.57 | 2.57 | 2.719B | -8.51% | 2719M |
FQ2 2024 (Jun 2024) | 2.47 | 2.47 | 2.8013B | -0.18% | 2801.3M |
FQ1 2024 (Mar 2024) | 1.65 | 1.65 | 2.6794B | 100% | 2679.4M |
FQ4 2023 (Dec 2023) | 2.19 | 2.19 | 2.61228B | -11.69% | 2612.28M |
FQ3 2023 (Jul 2023) | 1.59 | 1.59 | 2.95043B | -6.87% | 2950.43M |
FQ2 2023 (Apr 2023) | 1.26 | 1.26 | 2.80622B | 100% | 2806.22M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 3.1721 | -- | 2.92005 | 3.28129 | 6 |
FQ3 2027 (Sep 2027) | 4.6566 | -- | 4.28659 | 4.81689 | 6 |
FQ2 2027 (Jun 2027) | 4.7503 | -- | 4.37285 | 4.91382 | 6 |
FQ1 2027 (Mar 2027) | 2.729 | -- | 2.51216 | 2.82294 | 6 |
FQ4 2026 (Dec 2026) | 3.12 | -- | 3.03131 | 3.26706 | 2 |
FQ3 2026 (Sep 2026) | 4.15 | -- | 4.03203 | 4.3456 | 2 |
FQ2 2026 (Jun 2026) | 4.15 | -- | 4.03203 | 4.3456 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 3.01B | -- | 2.83B | 3.09B | 4 |
FQ3 2027 (Sep 2027) | 2.99B | -- | 2.8B | 3.07B | 7 |
FQ2 2027 (Jun 2027) | 2.96B | -- | 2.78B | 3.04B | 4 |
FQ1 2027 (Mar 2027) | 2.94B | -- | 2.76B | 3.02B | 7 |
FQ4 2026 (Dec 2026) | 2.67B | -- | 2.61B | 2.76B | 3 |
FQ3 2026 (Sep 2026) | 2.79B | -- | 2.73B | 2.89B | 3 |
FQ2 2026 (Jun 2026) | 2.81B | -- | 2.74B | 2.91B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.16 | 1.16 | 100% | |
FQ4 2024 (Dec 2024) | 1.48 | 1.48 | 100% | |
FQ3 2024 (Sep 2024) | 2.57 | 2.57 | 100% | |
FQ2 2024 (Jun 2024) | 2.47 | 2.47 | 100% | |
FQ1 2024 (Mar 2024) | 1.65 | 1.65 | 100% | |
FQ4 2023 (Dec 2023) | 2.19 | 2.19 | 100% | |
FQ3 2023 (Jul 2023) | 1.59 | 1.59 | 100% | |
FQ2 2023 (Apr 2023) | 1.26 | 1.26 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $2.53B | $2525.8M | 100% |
FQ4 2024 (Dec 2024) | $0B | $2.64B | $2637.2M | 100% |
FQ3 2024 (Sep 2024) | $0B | $2.72B | $2719M | 100% |
FQ2 2024 (Jun 2024) | $0B | $2.8B | $2801.3M | 100% |
FQ1 2024 (Mar 2024) | $0B | $2.68B | $2679.4M | 100% |
FQ4 2023 (Dec 2023) | $0B | $2.61B | $2612.28M | 100% |
FQ3 2023 (Jul 2023) | $0B | $2.95B | $2950.43M | 100% |
FQ2 2023 (Apr 2023) | $0B | $2.81B | $2806.22M | 100% |